{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:35:07Z","timestamp":1789799707087,"version":"4.0.1"},"reference-count":149,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T00:00:00Z","timestamp":1625011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Amyotrophic Lateral Sclerosis (ALS) is a devastating progressive neurodegenerative disease that affects motor neurons, leading to a relentless paralysis of skeletal muscles and eventual respiratory failure. Although a small percentage of patients may have a longer survival time (up to 10 years), in most cases, the median survival time is from 20 to 48 months. The pathogenesis and risk factors for ALS are still unclear: among the various aspects taken into consideration, metabolic abnormalities and nutritional factors have been the focus of recent interests. Although there are no consistent findings regarding prior type-2 diabetes, hypercholesterolemia and ALS incidence, abnormalities in lipid and glucose metabolism may be linked to disease progression, leading to a relatively longer survival (probably as a result of counteract malnutrition and cachexia in the advanced stages of the disease). Among potential dietary risk factors, a higher risk of ALS has been associated with an increased intake of glutamate, while the consumption of antioxidant and anti-inflammatory compounds, such as vitamin E, n-3 polyunsaturated fatty acids, and carotenoids, has been related to lower incidence. Poor nutritional status and weight loss in ALS resulting from poor oral intake, progressive muscle atrophy, and the potential hypermetabolic state have been associated with rapid disease progression. It seems important to routinely perform a nutritional assessment of ALS patients at the earliest referral: weight maintenance (if adequate) or gain (if underweight) is suggested from the scientific literature; evidence of improved diet quality (in terms of nutrients and limits for pro-inflammatory dietary factors) and glucose and lipid control is yet to be confirmed, but it is advised. Further research is warranted to better understand the role of nutrition and the underlying metabolic abnormalities in ALS, and their contribution to the pathogenic mechanisms leading to ALS initiation and progression.<\/jats:p>","DOI":"10.3390\/nu13072273","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T10:03:19Z","timestamp":1625047399000},"page":"2273","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7494-9057","authenticated-orcid":false,"given":"Emanuele","family":"D\u2019Amico","sequence":"first","affiliation":[{"name":"Department G.F. Ingrassia, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-5285","authenticated-orcid":false,"given":"Giuseppe","family":"Grosso","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8593-343X","authenticated-orcid":false,"given":"Jeri W.","family":"Nieves","sequence":"additional","affiliation":[{"name":"Mailman School of Public Health and Institute of Human Nutrition, Columbia University, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Zangh\u00ec","sequence":"additional","affiliation":[{"name":"Department G.F. Ingrassia, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam","family":"Factor-Litvak","sequence":"additional","affiliation":[{"name":"Mailman School of Public Health and Institute of Human Nutrition, Columbia University, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mitsumoto","sequence":"additional","affiliation":[{"name":"Eleanor and Lou Gehrig ALS Center, The Neurological Institute of New York Columbia University Medical Center, New York, NY 10032, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-277X.2010.01057.x","article-title":"Nutritional Factors Associated with Survival Following Enteral Tube Feeding in Patients with Motor Neurone Disease","volume":"23","author":"Rio","year":"2010","journal-title":"J. Hum. Nutr. Diet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","article-title":"Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature","volume":"41","author":"Logroscino","year":"2013","journal-title":"Neuroepidemiology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/17482968.2010.502940","article-title":"The Epidemiology and Treatment of ALS: Focus on the Heterogeneity of the Disease and Critical Appraisal of Therapeutic Trials","volume":"12","author":"Beghi","year":"2011","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrneurol.2011.150","article-title":"Clinical Genetics of Amyotrophic Lateral Sclerosis: What Do We Really Know?","volume":"7","author":"Andersen","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic Lateral Sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ncl.2004.12.016","article-title":"Amyotrophic Lateral Sclerosis: Possible Role of Environmental Influences","volume":"23","author":"Wicklund","year":"2005","journal-title":"Neurol. Clin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/09637486.2019.1580682","article-title":"The Human-Microbiome Superorganism and Its Modulation to Restore Health","volume":"70","author":"Salvucci","year":"2019","journal-title":"Int. J. Food Sci. Nutr."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Di Gioia, D., Bozzi Cionci, N., Baffoni, L., Amoruso, A., Pane, M., Mogna, L., Gagg\u00eca, F., Lucenti, M.A., Bersano, E., and Cantello, R. (2020). A Prospective Longitudinal Study on the Microbiota Composition in Amyotrophic Lateral Sclerosis. BMC Med., 18.","DOI":"10.1186\/s12916-020-01607-9"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic Lateral Sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2217\/bmm-2018-0149","article-title":"Progress and New Frontiers in Biomarkers for Amyotrophic Lateral Sclerosis","volume":"12","author":"Turner","year":"2018","journal-title":"Biomark. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Grad, L.I., Rouleau, G.A., Ravits, J., and Cashman, N.R. (2017). Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS). Cold Spring Harb. Perspect. Med., 7.","DOI":"10.1101\/cshperspect.a024117"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/WNL.0b013e3181bc01a4","article-title":"Practice Parameter Update: The Care of the Patient with Amyotrophic Lateral Sclerosis: Multidisciplinary Care, Symptom Management, and Cognitive\/Behavioral Impairment (an Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"73","author":"Miller","year":"2009","journal-title":"Neurology"},{"key":"ref_13","unstructured":"(2017). Writing Group; Edaravone (MCI-186) ALS 19 Study Group Safety and Efficacy of Edaravone in Well Defined Patients with Amyotrophic Lateral Sclerosis: A Randomised, Double-Blind, Placebo-Controlled Trial. Lancet Neurol., 16, 505\u2013512."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/21678421.2018.1517179","article-title":"Is Edaravone Harmful? (A Placebo Is Not a Control)","volume":"19","author":"Turnbull","year":"2018","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S1474-4422(20)30265-9","article-title":"Reappraisal of an ALS Trial: Unaccounted Procedural Risk","volume":"19","author":"Turnbull","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1002\/ana.21556","article-title":"Outcomes Research in Amyotrophic Lateral Sclerosis: Lessons Learned from the Amyotrophic Lateral Sclerosis Clinical Assessment, Research, and Education Database","volume":"65","author":"Miller","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1212\/01.wnl.0000437305.37850.f9","article-title":"Quality Improvement in Neurology: Amyotrophic Lateral Sclerosis Quality Measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology","volume":"81","author":"Miller","year":"2013","journal-title":"Neurology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1212\/WNL.52.7.1311","article-title":"Practice Parameter: The Care of the Patient with Amyotrophic Lateral Sclerosis (an Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force","volume":"52","author":"Miller","year":"1999","journal-title":"Neurology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"17652","DOI":"10.1038\/s41598-017-17389-9","article-title":"Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS","volume":"7","author":"Blasco","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1194\/jlr.P071639","article-title":"Defective Cholesterol Metabolism in Amyotrophic Lateral Sclerosis","volume":"58","author":"Yutuc","year":"2017","journal-title":"J. Lipid Res."},{"key":"ref_21","first-page":"611","article-title":"Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments","volume":"10","author":"Tefera","year":"2016","journal-title":"Front. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"12262","DOI":"10.1038\/s41598-019-48831-9","article-title":"Body Weight Variation Predicts Disease Progression after Invasive Ventilation in Amyotrophic Lateral Sclerosis","volume":"9","author":"Nakayama","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Godos, J., Currenti, W., Angelino, D., Mena, P., Castellano, S., Caraci, F., Galvano, F., Del Rio, D., Ferri, R., and Grosso, G. (2020). Diet and mental health: Review of the recent updates on molecular mechanisms. Antioxidants, 9.","DOI":"10.3390\/antiox9040346"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/21678421.2017.1360355","article-title":"Nutrition Management Methods Effective in Increasing Weight, Survival Time and Functional Status in ALS Patients: A Systematic Review","volume":"19","author":"Kellogg","year":"2018","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","article-title":"Energy Metabolism in Amyotrophic Lateral Sclerosis","volume":"10","author":"Dupuis","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000369812","article-title":"Antecedent Disease Is Less Prevalent in Amyotrophic Lateral Sclerosis","volume":"15","author":"Mitchell","year":"2015","journal-title":"Neurodegener. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0022-510X(84)90154-0","article-title":"Insulin Resistance in Amyotrophic Lateral Sclerosis","volume":"63","author":"Reyes","year":"1984","journal-title":"J. Neurol. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1212\/WNL.37.8.1375","article-title":"Reduction in Insulin Receptors in Amyotrophic Lateral Sclerosis Correlates with Reduced Insulin Sensitivity","volume":"37","author":"Perurena","year":"1987","journal-title":"Neurology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1600-0404.1984.tb00851.x","article-title":"Glucose Tolerance in Amyotrophic Lateral Sclerosis","volume":"70","author":"Harno","year":"1984","journal-title":"Acta Neurol. Scand."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/ene.12660","article-title":"Diabetes Mellitus in Amyotrophic Lateral Sclerosis: Dr. Jekyll or Mr. Hyde?","volume":"22","author":"Jawaid","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/dc06-0062","article-title":"Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. Population: National Health And Nutrition Examination Survey 1999\u20132002","volume":"29","author":"Cowie","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ana.24936","article-title":"Blood Biomarkers of Carbohydrate, Lipid, and Apolipoprotein Metabolisms and Risk of Amyotrophic Lateral Sclerosis: A More than 20-Year Follow-up of the Swedish AMORIS Cohort","volume":"81","author":"Mariosa","year":"2017","journal-title":"Ann. Neurol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1468-1331.2009.02923.x","article-title":"ALS Disease Onset May Occur Later in Patients with Pre-Morbid Diabetes Mellitus","volume":"17","author":"Jawaid","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/ene.13465","article-title":"The Role of Pre-Morbid Diabetes on Developing Amyotrophic Lateral Sclerosis","volume":"25","author":"Calvo","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/ene.14300","article-title":"Diabetes Mellitus and Prognosis of Amyotrophic Lateral Sclerosis: Data from 501 Patients of a Population-Based Registry in Southwest Germany","volume":"27","author":"Schumacher","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/mus.24688","article-title":"Pre-Morbid Type 2 Diabetes Mellitus Is Not a Prognostic Factor in Amyotrophic Lateral Sclerosis","volume":"52","author":"Paganoni","year":"2015","journal-title":"Muscle Nerve"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2188\/jea.JE20140176","article-title":"Risk of Amyotrophic Lateral Sclerosis in Patients with Diabetes: A Nationwide Population-Based Cohort Study","volume":"25","author":"Sun","year":"2015","journal-title":"J. Epidemiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13024-017-0211-y","article-title":"Blood Hemoglobin A1c Levels and Amyotrophic Lateral Sclerosis Survival","volume":"12","author":"Wei","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/ene.12632","article-title":"Association between Diabetes and Amyotrophic Lateral Sclerosis in Sweden","volume":"22","author":"Mariosa","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000353158","article-title":"Trials of Antidiabetic Drugs in Amyotrophic Lateral Sclerosis: Proceed with Caution?","volume":"13","author":"Jawaid","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"526","DOI":"10.15252\/emmm.201404433","article-title":"A Metabolic Switch toward Lipid Use in Glycolytic Muscle Is an Early Pathologic Event in a Mouse Model of Amyotrophic Lateral Sclerosis","volume":"7","author":"Palamiuc","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/jcbfm.2011.155","article-title":"Early and Progressive Impairment of Spinal Blood Flow-Glucose Metabolism Coupling in Motor Neuron Degeneration of ALS Model Mice","volume":"32","author":"Miyazaki","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00259-013-2667-5","article-title":"The Metabolic Signature of C9ORF72-Related ALS: FDG PET Comparison with Nonmutated Patients","volume":"41","author":"Cistaro","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7821672","DOI":"10.1155\/2017\/7821672","article-title":"What Is \u201cHyper\u201d in the ALS Hypermetabolism?","volume":"2017","author":"Ferri","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1002\/jcp.29682","article-title":"Glucose, Glycolysis, and Neurodegenerative Diseases","volume":"235","author":"Tang","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/17482960902822960","article-title":"Impaired Glucose Tolerance in Patients with Amyotrophic Lateral Sclerosis","volume":"11","author":"Pradat","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1212\/WNL.22.5.528","article-title":"Vascular and Metabolic Studies of Amyotrophic Lateral Sclerosis. II. Lipid and Carbohydrate Metabolism","volume":"22","author":"Gustafson","year":"1972","journal-title":"Neurology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","article-title":"Dyslipidemia Is a Protective Factor in Amyotrophic Lateral Sclerosis","volume":"70","author":"Dupuis","year":"2008","journal-title":"Neurology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1212\/WNL.0b013e3181c1df1e","article-title":"Lower Serum Lipid Levels Are Related to Respiratory Impairment in Patients with ALS","volume":"73","author":"Calvo","year":"2009","journal-title":"Neurology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00415-010-5805-z","article-title":"Patients with Elevated Triglyceride and Cholesterol Serum Levels Have a Prolonged Survival in Amyotrophic Lateral Sclerosis","volume":"258","author":"Dorst","year":"2011","journal-title":"J. Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp.2010.236752","article-title":"Beneficial Vascular Risk Profile Is Associated with Amyotrophic Lateral Sclerosis","volume":"82","author":"Sutedja","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/mus.22114","article-title":"Body Mass Index, Not Dyslipidemia, Is an Independent Predictor of Survival in Amyotrophic Lateral Sclerosis","volume":"44","author":"Paganoni","year":"2011","journal-title":"Muscle Nerve"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2169\/internalmedicine.51.7465","article-title":"Relationships between Disease Progression and Serum Levels of Lipid, Urate, Creatinine and Ferritin in Japanese Patients with Amyotrophic Lateral Sclerosis: A Cross-Sectional Study","volume":"51","author":"Ikeda","year":"2012","journal-title":"Intern. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1179\/1743132812Y.0000000049","article-title":"Is Hyperlipidemia Correlated with Longer Survival in Patients with Amyotrophic Lateral Sclerosis?","volume":"34","author":"Dedic","year":"2012","journal-title":"Neurol. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3988\/jcn.2013.9.2.125","article-title":"Hypolipidemia in Patients with Amyotrophic Lateral Sclerosis: A Possible Gender Difference?","volume":"9","author":"Yang","year":"2013","journal-title":"J. Clin. Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/21678421.2015.1047454","article-title":"The Serum Lipid Profiles of Amyotrophic Lateral Sclerosis Patients: A Study from South-West China and a Meta-Analysis","volume":"16","author":"Huang","year":"2015","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s10072-017-3138-8","article-title":"Changes in Routine Laboratory Tests and Survival in Amyotrophic Lateral Sclerosis","volume":"38","author":"Mandrioli","year":"2017","journal-title":"Neurol. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jns.2017.07.019","article-title":"Low IDL-B and High LDL-1 Subfraction Levels in Serum of ALS Patients","volume":"380","author":"Delaye","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e1835","DOI":"10.1212\/WNL.0000000000009322","article-title":"Lipids, Apolipoproteins, and Prognosis of Amyotrophic Lateral Sclerosis","volume":"94","author":"Ingre","year":"2020","journal-title":"Neurology"},{"key":"ref_60","first-page":"452","article-title":"Abdominal Obesity as Important Component of Insulin-Resistance Syndrome","volume":"9","year":"1993","journal-title":"Nutrition"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/jnnp.2010.211474","article-title":"Alteration of Nutritional Status at Diagnosis Is a Prognostic Factor for Survival of Amyotrophic Lateral Sclerosis Patients","volume":"82","author":"Marin","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/ajcn\/77.5.1179","article-title":"Validation of Bioelectrical Impedance Analysis in Patients with Amyotrophic Lateral Sclerosis","volume":"77","author":"Desport","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mus.24419","article-title":"Nutritional Assessment of Amyotrophic Lateral Sclerosis in Routine Practice: Value of Weighing and Bioelectrical Impedance Analysis","volume":"51","author":"Roubeau","year":"2015","journal-title":"Muscle Nerve"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Lindauer, E., Dupuis, L., M\u00fcller, H.-P., Neumann, H., Ludolph, A.C., and Kassubek, J. (2013). Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067783"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.psym.2019.11.002","article-title":"Neuroendocrine Disturbances in Neurodegenerative Disorders: A Scoping Review","volume":"61","author":"Newhouse","year":"2020","journal-title":"Psychosomatics"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ene.13481","article-title":"Diabetes Mellitus and Amyotrophic Lateral Sclerosis: Time to Bridge the Gap between the Bench and the Bedside","volume":"25","author":"Jawaid","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40265-016-0674-0","article-title":"Insulin Resistance and Neurodegeneration: Progress towards the Development of New Therapeutics for Alzheimer\u2019s Disease","volume":"77","year":"2017","journal-title":"Drugs"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for Care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/S0140-6736(02)09089-X","article-title":"Glucose Metabolism in Patients with Acute Myocardial Infarction and No Previous Diagnosis of Diabetes Mellitus: A Prospective Study","volume":"359","author":"Norhammar","year":"2002","journal-title":"Lancet"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2217\/17460875.2.4.403","article-title":"Role of Lipids in Brain Injury and Diseases","volume":"2","author":"Adibhatla","year":"2007","journal-title":"Future Lipidol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fncel.2014.00025","article-title":"A Plural Role for Lipids in Motor Neuron Diseases: Energy, Signaling and Structure","volume":"8","author":"Schmitt","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fneur.2019.00284","article-title":"Lipid Biomarkers for Amyotrophic Lateral Sclerosis","volume":"10","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/156720511795563700","article-title":"FTD and ALS: A Tale of Two Diseases","volume":"8","author":"Ferrari","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3233\/JAD-170660","article-title":"Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition","volume":"61","author":"Ahmed","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/21678421.2020.1822411","article-title":"Pre-Diagnostic Plasma Lipid Levels and the Risk of Amyotrophic Lateral Sclerosis","volume":"22","author":"Bjornevik","year":"2021","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1212\/01.wnl.0000327866.54482.f1","article-title":"Dyslipidemia Is a Protective Factor in Amyotrophic Lateral Sclerosis","volume":"71","author":"Goldstein","year":"2008","journal-title":"Neurology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1212\/01.wnl.0000339397.79460.d5","article-title":"Re: Dyslipidemia Is a Protective Factor in Amyotrophic Lateral Sclerosis","volume":"72","author":"Yoshii","year":"2009","journal-title":"Neurology"},{"key":"ref_78","first-page":"1","article-title":"Effect of Lipid Profile on Prognosis in the Patients with Amyotrophic Lateral Sclerosis: Insights from the Olesoxime Clinical Trial","volume":"16","author":"Rafiq","year":"2015","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2990.2011.01166.x","article-title":"Review: The Role of Mitochondria in the Pathogenesis of Amyotrophic Lateral Sclerosis","volume":"37","author":"Duffy","year":"2011","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2015.08.004","article-title":"Mitochondria and Endoplasmic Reticulum Crosstalk in Amyotrophic Lateral Sclerosis","volume":"90","author":"Manfredi","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"132933","DOI":"10.1016\/j.neulet.2017.06.052","article-title":"The Role of Mitochondria in Amyotrophic Lateral Sclerosis","volume":"710","author":"Smith","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/archneur.1987.00520130079022","article-title":"Hepatic Ultrastructural Changes and Liver Dysfunction in Amyotrophic Lateral Sclerosis","volume":"44","author":"Nakano","year":"1987","journal-title":"Arch. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ecl.2008.06.006","article-title":"Mitochondrial Dysfunction in Type 2 Diabetes and Obesity","volume":"37","author":"Mogensen","year":"2008","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s40142-017-0123-8","article-title":"Metabolic Dysregulation in Amyotrophic Lateral Sclerosis: Challenges and Opportunities","volume":"5","author":"Joardar","year":"2017","journal-title":"Curr. Genet. Med. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/NT.0000000000000092","article-title":"Body Mass Index: Obesity, BMI, and Health: A Critical Review","volume":"50","author":"Nuttall","year":"2015","journal-title":"Nutr. Today"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/21678421.2018.1452944","article-title":"Prediagnostic Body Size and Risk of Amyotrophic Lateral Sclerosis Death in 10 Studies","volume":"19","author":"Wang","year":"2018","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.0b013e3182840689","article-title":"Prediagnostic Body Fat and Risk of Death from Amyotrophic Lateral Sclerosis: The EPIC Cohort","volume":"80","author":"Gallo","year":"2013","journal-title":"Neurology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/21678421.2012.735240","article-title":"Premorbid Body Mass Index and Risk of Amyotrophic Lateral Sclerosis","volume":"14","author":"Wang","year":"2013","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1079\/PHN2002394","article-title":"European Prospective Investigation into Cancer and Nutrition (EPIC): Study Populations and Data Collection","volume":"5","author":"Riboli","year":"2002","journal-title":"Public Health Nutr."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/mus.880161109","article-title":"Neuromuscular Transmission in Amyotrophic Lateral Sclerosis","volume":"16","author":"Maselli","year":"1993","journal-title":"Muscle Nerve"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/ncpneuro0853","article-title":"Diagnosis and Treatment of Bulbar Symptoms in Amyotrophic Lateral Sclerosis","volume":"4","author":"Gdynia","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2014.02.035","article-title":"Body Mass Index and Dietary Intervention: Implications for Prognosis of Amyotrophic Lateral Sclerosis","volume":"340","author":"Ngo","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/jnnp-2020-322909","article-title":"Prognostic Value of Weight Loss in Patients with Amyotrophic Lateral Sclerosis: A Population-Based Study","volume":"91","author":"Tan","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-7075-1-5","article-title":"Diet Induced Thermogenesis","volume":"1","author":"Westerterp","year":"2004","journal-title":"Nutr. Metab."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3945\/ajcn.113.069997","article-title":"Estimating Daily Energy Expenditure in Individuals with Amyotrophic Lateral Sclerosis","volume":"99","author":"Kasarskis","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-8223(98)00100-X","article-title":"The Harris-Benedict Studies of Human Basal Metabolism","volume":"98","author":"Frankenfield","year":"1998","journal-title":"J. Am. Diet. Assoc."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2008.12.027","article-title":"Do Patients with Amyotrophic Lateral Sclerosis (ALS) Have Increased Energy Needs?","volume":"279","author":"Vaisman","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/14660820050515386","article-title":"Nutritional Assessment and Survival in ALS Patients","volume":"1","author":"Desport","year":"2000","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ajcn\/63.1.130","article-title":"Nutritional Status of Patients with Amyotrophic Lateral Sclerosis: Relation to the Proximity of Death","volume":"63","author":"Kasarskis","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.jada.2011.08.002","article-title":"Which Equation Best Predicts Energy Expenditure in Amyotrophic Lateral Sclerosis?","volume":"111","author":"Ellis","year":"2011","journal-title":"J. Am. Diet. Assoc."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/0148607104028006442","article-title":"Standard Equations Are Not Accurate in Assessing Resting Energy Expenditure in Patients with Amyotrophic Lateral Sclerosis","volume":"28","author":"Sherman","year":"2004","journal-title":"JPEN J. Parenter. Enter. Nutr."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.clnu.2011.06.004","article-title":"Nutritional State, Energy Intakes and Energy Expenditure of Amyotrophic Lateral Sclerosis (ALS) Patients","volume":"30","author":"Genton","year":"2011","journal-title":"Clin. Nutr."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ajcn\/74.3.328","article-title":"Factors Correlated with Hypermetabolism in Patients with Amyotrophic Lateral Sclerosis","volume":"74","author":"Desport","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000089626","article-title":"Hypermetabolism in ALS: Correlations with Clinical and Paraclinical Parameters","volume":"2","author":"Desport","year":"2005","journal-title":"Neurodegener. Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/17482960802295192","article-title":"High Metabolic Level in Patients with Familial Amyotrophic Lateral Sclerosis","volume":"10","author":"Funalot","year":"2009","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.nut.2015.05.025","article-title":"Association between Nutritional Status and Disease Severity Using the Amyotrophic Lateral Sclerosis (ALS) Functional Rating Scale in ALS Patients","volume":"31","author":"Park","year":"2015","journal-title":"Nutrition"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/ene.13468","article-title":"Hypermetabolism Is a Deleterious Prognostic Factor in Patients with Amyotrophic Lateral Sclerosis","volume":"25","author":"Fayemendy","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.nut.2016.06.007","article-title":"Association between Estimated Total Daily Energy Expenditure and Stage of Amyotrophic Lateral Sclerosis","volume":"33","author":"Lee","year":"2017","journal-title":"Nutrition"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/jnnp-2017-317887","article-title":"Hypermetabolism in ALS Is Associated with Greater Functional Decline and Shorter Survival","volume":"89","author":"Steyn","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s00415-009-5100-z","article-title":"Hypermetabolism in ALS Patients: An Early and Persistent Phenomenon","volume":"256","author":"Bouteloup","year":"2009","journal-title":"J. Neurol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1073160","article-title":"BetaAR Signaling Required for Diet-Induced Thermogenesis and Obesity Resistance","volume":"297","author":"Bachman","year":"2002","journal-title":"Science"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.wco.0000183114.76056.0e","article-title":"Autonomic Impairment in Amyotrophic Lateral Sclerosis","volume":"18","author":"Baltadzhieva","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.nut.2012.01.011","article-title":"Nutritional and Metabolic Support in Patients with Amyotrophic Lateral Sclerosis","volume":"28","author":"Muscaritoli","year":"2012","journal-title":"Nutrition"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"11159","DOI":"10.1073\/pnas.0402026101","article-title":"Evidence for Defective Energy Homeostasis in Amyotrophic Lateral Sclerosis: Benefit of a High-Energy Diet in a Transgenic Mouse Model","volume":"101","author":"Dupuis","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1194\/jlr.M700017-JLR200","article-title":"Increased Peripheral Lipid Clearance in an Animal Model of Amyotrophic Lateral Sclerosis","volume":"48","author":"Fergani","year":"2007","journal-title":"J. Lipid Res."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0197-0186(01)00125-5","article-title":"Mitochondrial Involvement in Amyotrophic Lateral Sclerosis","volume":"40","author":"Menzies","year":"2002","journal-title":"Neurochem. Int."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"10812","DOI":"10.1073\/pnas.1308421110","article-title":"Metabolic Signatures of Amyotrophic Lateral Sclerosis Reveal Insights into Disease Pathogenesis","volume":"110","author":"Dodge","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13024-017-0217-5","article-title":"Fibroblast Bioenergetics to Classify Amyotrophic Lateral Sclerosis Patients","volume":"12","author":"Konrad","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ana.24244","article-title":"Bioenergetic Markers in Skin Fibroblasts of Sporadic Amyotrophic Lateral Sclerosis and Progressive Lateral Sclerosis Patients","volume":"76","author":"Kirk","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1136\/jcp.2007.051813","article-title":"Nutritional Assessment: Its Role in the Provision of Nutritional Support","volume":"61","author":"Marshall","year":"2008","journal-title":"J. Clin. Pathol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: A New Definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"4S177","DOI":"10.1016\/S0035-3787(06)75183-9","article-title":"Nutritional Approach for Patients with Amyotrophic Lateral Sclerosis","volume":"162","author":"Piquet","year":"2006","journal-title":"Rev. Neurol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1212\/WNL.53.5.1059","article-title":"Nutritional Status Is a Prognostic Factor for Survival in ALS Patients","volume":"53","author":"Desport","year":"1999","journal-title":"Neurology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3109\/17482968.2010.482592","article-title":"A Decrease in Body Mass Index Is Associated with Faster Progression of Motor Symptoms and Shorter Survival in ALS","volume":"11","author":"Jawaid","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000442444","article-title":"Population-Based Evidence That Survival in Amyotrophic Lateral Sclerosis Is Related to Weight Loss at Diagnosis","volume":"16","author":"Marin","year":"2016","journal-title":"Neurodegener. Dis."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jns.2010.06.028","article-title":"Malnutrition at the Time of Diagnosis Is Associated with a Shorter Disease Duration in ALS","volume":"297","author":"Limousin","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3109\/17482968.2012.701309","article-title":"First Assessment at Home of Amyotrophic Lateral Sclerosis (ALS) Patients by a Nutrition Network in the French Region of Limousin","volume":"13","author":"Jesus","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/jnnp.74.5.687-a","article-title":"Persistent Bitter Taste as an Initial Symptom of Amyotrophic Lateral Sclerosis","volume":"74","author":"Petzold","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrneurol.2011.153","article-title":"Clinical Diagnosis and Management of Amyotrophic Lateral Sclerosis","volume":"7","author":"Hardiman","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/jamaneurol.2014.1214","article-title":"Dietary \u03c9-3 Polyunsaturated Fatty Acid Intake and Risk for Amyotrophic Lateral Sclerosis","volume":"71","author":"Fitzgerald","year":"2014","journal-title":"JAMA Neurol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2741\/3878","article-title":"Omega-3 Polyunsaturated Fatty Acids in the Brain: Metabolism and Neuroprotection","volume":"16","author":"Zhang","year":"2011","journal-title":"Front. Biosci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/oxfordjournals.aje.a010184","article-title":"Population-Based Case-Control Study of Amyotrophic Lateral Sclerosis in Western Washington State. II. Diet","volume":"151","author":"Nelson","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/EDE.0b013e3181632c5d","article-title":"Diet and Amyotrophic Lateral Sclerosis","volume":"19","author":"Morozova","year":"2008","journal-title":"Epidemiology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jamaneurol.2015.1584","article-title":"Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral Sclerosis","volume":"72","author":"Huisman","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/21678421.2017.1418002","article-title":"Amyotrophic Lateral Sclerosis and Food Intake","volume":"19","author":"Pupillo","year":"2018","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/17482960701472249","article-title":"Nutritional Status and Risk of Amyotrophic Lateral Sclerosis in Japan","volume":"8","author":"Okamoto","year":"2007","journal-title":"Amyotroph. Lateral Scler."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/jnnp.2005.083378","article-title":"Intake of Polyunsaturated Fatty Acids and Vitamin E Reduces the Risk of Developing Amyotrophic Lateral Sclerosis","volume":"78","author":"Veldink","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ana.20316","article-title":"Vitamin E Intake and Risk of Amyotrophic Lateral Sclerosis","volume":"57","author":"Ascherio","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000026258","article-title":"Dietary Intake of Calcium, Magnesium and Antioxidants in Relation to Risk of Amyotrophic Lateral Sclerosis","volume":"19","author":"Longnecker","year":"2000","journal-title":"Neuroepidemiology"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000201563","article-title":"Fruit and Vegetable Intake and Risk of Amyotrophic Lateral Sclerosis in Japan","volume":"32","author":"Okamoto","year":"2009","journal-title":"Neuroepidemiology"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/aje\/kwq416","article-title":"Vitamin E Intake and Risk of Amyotrophic Lateral Sclerosis: A Pooled Analysis of Data from 5 Prospective Cohort Studies","volume":"173","author":"Wang","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ana.23820","article-title":"Intakes of Vitamin C and Carotenoids and Risk of Amyotrophic Lateral Sclerosis: Pooled Results from 5 Cohort Studies","volume":"73","author":"Fitzgerald","year":"2013","journal-title":"Ann. Neurol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/21678421.2013.803577","article-title":"Magnesium Intake and Risk of Amyotrophic Lateral Sclerosis: Results from Five Large Cohort Studies","volume":"14","author":"Fondell","year":"2013","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1001\/jamaneurol.2016.3401","article-title":"Association between Dietary Intake and Function in Amyotrophic Lateral Sclerosis","volume":"73","author":"Nieves","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/1028415X.2018.1466459","article-title":"Association between Macronutrient Intake and Amyotrophic Lateral Sclerosis Prognosis","volume":"23","author":"Kim","year":"2020","journal-title":"Nutr. Neurosci."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0002-8223(96)00190-3","article-title":"Update on the Biological Characteristics of the Antioxidant Micronutrients: Vitamin C, Vitamin E, and the Carotenoids","volume":"96","author":"Rock","year":"1996","journal-title":"J. Am. Diet. Assoc."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.freeradbiomed.2009.11.018","article-title":"Oxidative Stress in ALS: Key Role in Motor Neuron Injury and Therapeutic Target","volume":"48","author":"Barber","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.freeradbiomed.2013.06.029","article-title":"Clinical Perspective on Oxidative Stress in Sporadic Amyotrophic Lateral Sclerosis","volume":"65","author":"Santella","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12263-009-0128-3","article-title":"Beta-Carotene Conversion Products and Their Effects on Adipose Tissue","volume":"4","author":"Tourniaire","year":"2009","journal-title":"Genes Nutr."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/7\/2273\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:24:01Z","timestamp":1760163841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/13\/7\/2273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,30]]},"references-count":149,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["nu13072273"],"URL":"https:\/\/doi.org\/10.3390\/nu13072273","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,30]]}}}